Large Cap

Trump Flips On Canada Trade Deal, Sending Shivers Through Wall Street

GSK Rebranded Flovent Asthma Inahler For Children To Avoid $367 Million Medicaid Rebate, Senator Hassan Accuses

Wall Street Hits Record Highs, Nike Jumps 18%: What's Moving Markets Friday?

GSK Rebranded Flovent Asthma Inahler For Children To Avoid $367 Million Medicaid Rebate, Senator Hassan Accuses

Wall Street Hits Record Highs, Nike Jumps 18%: What's Moving Markets Friday?

FDA Eases Rules For Bristol Myers' Cell Therapies For Blood Cancers

Spain Accuses Novo Nordisk Of Covert Advertising For Prescription Weight-Loss Drugs

FDA Eases Rules For Bristol Myers' Cell Therapies For Blood Cancers

Spain Accuses Novo Nordisk Of Covert Advertising For Prescription Weight-Loss Drugs

Investors Seek Gold Alternative - Platinum Hits $1,400 As Supply Deficit Deepens

RFK Jr's CDC Panel Recommends Merck's RSV Shot For Infants

Large Cap Recent News

Apple's F1 Movie Burns $300 Million—Still Waiting On A Profit

Apple's video production unit, which includes Apple Original Films and Apple TV+, has never turned a profit since its launch in 2017.

Palantir Is A '$200 Stock Masquerading As $144,' Says Jim Cramer: Highlights New Nuclear Operating System, Microsoft Endorsement

TV host Jim Cramer has once again thrown his weight behind Palantir Technologies Inc., this time with a striking new valuation claim.

Amazon Loses Top AI Leader In High-Stakes Talent Shuffle

Vasi Philomin left Amazon earlier in June after eight years with the company.

Elanco Animal Health Gets Its Bite Back, Pipeline Efforts Earn Praise

Elanco upgraded to Outperform by William Blair as pipeline gains traction and EMA backs Zenrelia ahead of expected Q3 approval.

Pfizer Seeks Label Expansion For Hemophilia Drug After Promising Data

Pfizer's Hympavzi showed superior bleed control in hemophilia A and B patients with inhibitors, reducing bleeding rates and showing good tolerability.

Stocks Rally To New Highs, Dollar Tumbles To 40-Month Lows: What's Driving Markets Thursday?

Wall Street entered full rally mode on Thursday, with the Nasdaq 100 extending its record-setting climb and the S&P 500 approaching its February peak, as easing geopolitical fears and renewed hopes for a dovish Federal Reserve lifted investor sentiment.

Walgreens Crushes Sales Forecast, But Deeper Retail Troubles Lurk Beneath

Walgreens reported Q3 revenue of $38.99 billion and adjusted EPS of 38 cents, topping estimates as healthcare gains helped offset weaker retail sales.

Mars Just Got The Green Light For Its $36B Deal — But Europe Might Blow It Up

Mars' $36 billion acquisition of Kellanova clears FTC review, but EU raises concerns about pricing power and retailer negotiations in the EEA.

Shell Squashes BP Takeover Rumors, Hits Six-Month Ban

Shell said it has no plans to acquire BP, rejecting media reports and confirming no talks have occurred under the UK Takeover Code's Rule 2.8.

Micron CEO Cautions AI Boom May Not Be Fully Sustainable, Flags Tariff-Driven Demand Pull-In

During Micron Technology Inc.'s (NASDAQ: MU) third quarter results, the company's CEO, Sanjay Mehrotra, warned investors that not all of the AI-fueled demand surge may be sustainable.

FDA Sounds Alarm After 33 Injuries Tied To Medtronic Device Malfunction

FDA highlights risks from recalled Medtronic devices tied to esophageal injuries and faulty cannulas, with serious health concerns and product warnings issued.

Subprime Was A Trainwreck In 2008―Now It's A Sweet Spot, Says Goldman Sachs

Goldman Sachs says subprime consumers are stronger than expected, with falling delinquencies and steady spending. Eight stocks could benefit from this unexpected resilience.

Biogen-Ionis Partnered Drug Shows Benefit In Children With Spinal Muscular Atrophy Previously Treated With Novartis' Zolgensma

Biogen's early-stage spinal muscular atrophy drug salanersen showed safety, motor improvements and 70% reduction in neurodegeneration markers after one-year dosing.